有关风湿性关节炎相关的间歇性肺部疾病的机会窗口存在吗?
Mitsuhiro Akiyama1, Waleed Alshehri1, Yuko Kaneko1
1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Autoimmunity reviews
|December 12, 2023
概括
早期类风湿性关节炎 (RA) 治疗是关节健康的关键. 实现RA缓解也可以防止RA相关间歇性肺病 (RA-ILD) 的肺纤维化进展.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种自身免疫性疾病,导致慢性肌炎和关节破坏.
- 分子向疗法和治疗到向策略可以改善RA患者的日常生活.
- 间歇性肺病 (ILD) 是一种严重的关节外并发症,影响RA预后.
研究的目的:
- 审查RA-ILD的临床和放射学特征.
- 讨论RA-ILD的当前和新兴治疗策略.
- 突出早期干预对RA关节和肺结局的重要性.
主要方法:
- 关于RA和RA-ILD管理的最新进展的文献综述.
- 对RA-ILD的临床和放射学数据的分析.
- 综合有关疾病行为和进展模式的证据.
主要成果:
- 早期的RA诊断和治疗对于共同的结果至关重要.
- 实现RA缓解对于预防RA-ILD肺纤维化进展至关重要.
- RA-ILD表现出各种疾病行为,需要进一步研究.
结论:
- 对于管理RA联接点和RA-ILD.存在一个"机会窗口".
- 了解RA-ILD异质性对于个性化治疗至关重要.
- 需要进一步的证据来准确确定RA-ILD疾病行为和优化管理.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Pulmonary Tuberculosis II
240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Drugs Used in Lower Respiratory Disorders: Overview
450
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
450


